These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 24115193)
1. Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN. Gou SJ; Yuan J; Wang C; Zhao MH; Chen M Clin J Am Soc Nephrol; 2013 Nov; 8(11):1884-91. PubMed ID: 24115193 [TBL] [Abstract][Full Text] [Related]
4. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival. Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P Front Immunol; 2021; 12():625672. PubMed ID: 33841408 [TBL] [Abstract][Full Text] [Related]
5. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN. Zhao L; David MZ; Hyjek E; Chang A; Meehan SM Clin J Am Soc Nephrol; 2015 Jan; 10(1):54-62. PubMed ID: 25516918 [TBL] [Abstract][Full Text] [Related]
6. Complement in ANCA-associated vasculitis. Charles Jennette J; Xiao H; Hu P Semin Nephrol; 2013 Nov; 33(6):557-64. PubMed ID: 24161040 [TBL] [Abstract][Full Text] [Related]
7. Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis. Manenti L; Vaglio A; Gnappi E; Maggiore U; Allegri L; Allinovi M; Urban ML; Delsante M; Galetti M; Nicastro M; Pilato FP; Buzio C Clin J Am Soc Nephrol; 2015 Dec; 10(12):2143-51. PubMed ID: 26542163 [TBL] [Abstract][Full Text] [Related]
8. Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis. Chen SF; Wang FM; Li ZY; Yu F; Zhao MH; Chen M Arthritis Res Ther; 2015 May; 17(1):129. PubMed ID: 25994214 [TBL] [Abstract][Full Text] [Related]
9. C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Yuan J; Gou SJ; Huang J; Hao J; Chen M; Zhao MH Arthritis Res Ther; 2012 Jun; 14(3):R140. PubMed ID: 22691190 [TBL] [Abstract][Full Text] [Related]
10. Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis. Hakroush S; Tampe D; Ströbel P; Korsten P; Tampe B Front Immunol; 2021; 12():737708. PubMed ID: 34759920 [TBL] [Abstract][Full Text] [Related]
11. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis. Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415 [TBL] [Abstract][Full Text] [Related]
12. Systemic complement activation in anti-neutrophil cytoplasmic antibody-associated vasculitis and necrotizing glomerulonephritis. Bantis K; Stangou M; Kalpakidis S; Hatziadamou M; Daikidou DV; Lioulios G; Mitsoglou Z; Chatzidrosou H; Nikolaidou C; Fylaktou A; Papagianni A Nephrology (Carlton); 2021 Jan; 26(1):30-37. PubMed ID: 32602136 [TBL] [Abstract][Full Text] [Related]
14. Complement regulatory proteins in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Cheng L; Gou SJ; Qiu HY; Ma L; Fu P Clin Exp Immunol; 2018 Jan; 191(1):116-124. PubMed ID: 28940198 [TBL] [Abstract][Full Text] [Related]
15. Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis. Hilhorst M; Maria AT; Kavian N; Batteux F; Borderie D; Le Quellec A; van Paassen P; Guilpain P Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1769-F1776. PubMed ID: 30207165 [TBL] [Abstract][Full Text] [Related]
16. [Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis]. Bulanov NM; Serova AG; Kuznetsova EI; Bulanova ML; Novikov PI; Kozlovskaya LV; Moiseev SV Ter Arkh; 2017; 89(6):48-55. PubMed ID: 28745689 [TBL] [Abstract][Full Text] [Related]
17. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis. Shah S; Havill J; Rahman MH; Geetha D Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939 [TBL] [Abstract][Full Text] [Related]
18. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters? Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223 [TBL] [Abstract][Full Text] [Related]
19. Complement in ANCA-associated glomerulonephritis. Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW; Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil extracellular traps can activate alternative complement pathways. Wang H; Wang C; Zhao MH; Chen M Clin Exp Immunol; 2015 Sep; 181(3):518-27. PubMed ID: 25963026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]